Kresnier Perez

The role of a headhunter in clinical research is multifaceted and critical to the success of organizations seeking specialized talent. Headhunters, often referred to as executive recruiters, are tasked with identifying, attracting, and securing top-tier professionals who possess the necessary skills and experience to drive clinical trials and research initiatives forward. In the clinical research […]

The Electronic Trial Master File (ETMF) system represents a significant evolution in the management of clinical trial documentation. Traditionally, the Trial Master File (TMF) was a physical collection of essential documents that provided evidence of the conduct of a clinical trial and the integrity of the data collected. However, as the clinical research landscape has

Tirzepatide, a novel medication developed by Eli Lilly and Company, represents a significant advancement in the treatment of type 2 diabetes. This innovative drug is a dual agonist, targeting both the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor. By simultaneously activating these two pathways, tirzepatide enhances insulin secretion, reduces glucagon levels,

The Topaz 1 Trial represents a significant advancement in the field of medical research, particularly in the treatment of certain malignancies. This clinical trial was designed to evaluate the efficacy and safety of a novel therapeutic agent, which has garnered attention for its potential to improve patient outcomes in a landscape where treatment options are

The Topaz 1 Trial represents a significant advancement in the realm of clinical research, particularly in the treatment of certain malignancies. This trial is part of a broader effort to explore innovative therapies that can enhance patient outcomes and improve quality of life. Conducted with a diverse cohort of participants, the Topaz 1 Trial aims

Electronic Patient-Reported Outcomes (Epro) have emerged as a transformative tool in the landscape of clinical trials, revolutionizing how patient data is collected and utilized. Traditionally, clinical trials relied heavily on paper-based methods for gathering patient-reported outcomes, which often led to inefficiencies, data inaccuracies, and challenges in patient engagement. Epro systems leverage digital technology to streamline